Early heparin therapy in patients with spontaneous intracerebral haemorrhage.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1865215.
- Also identified by PMC identifier 488553.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 68 patients with spontaneous intracerebral haemorrhage the effect of heparin treatment beginning on the second, fourth or tenth day was investigated. Early (day 2) low-dose heparin medication significantly lowered the incidence of pulmonary embolism. An increase in the number of patients with rebleeding was not observed. The results indicate that the early use of heparin in these patients is safe and can be recommended for the prevention of thromboembolic complications.
Medical subject headings
- Cerebral Hemorrhage
- Heparin